Analysis of acylcarnitine profiles in umbilical cord blood and during the early neonatal period by electrospray ionization tandem mass spectrometry

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 6, 2012, Pages 546-556

  Vieira Neto, E ^a,b   Fonseca, A A ^b   Almeida, R F ^b   Figueiredo, M P ^a   Porto, M A S ^a   Ribeiro, M G ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Laboratório Diagnósticos Laboratoriais Especializados   (Brazil)

Author keywords

Acylcarnitine; Carnitine; Cord blood; Electrospray ionization mass spectrometry; Newborn infants; Reference values

Indexed keywords

ACYLCARNITINE; CARNITINE OLEATE; FATTY ACID ESTER; PALMITOYLCARNITINE; PROPIONYLCARNITINE; STEAROYLCARNITINE; UNCLASSIFIED DRUG;

ARTICLE; BIRTH WEIGHT; BREAST MILK; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; INFANT; LIPID ANALYSIS; MALE; NEWBORN; NEWBORN PERIOD; NORMAL HUMAN; TANDEM MASS SPECTROMETRY; UMBILICAL CORD BLOOD;

EID: 84862004213     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500056     Document Type: Article

References (40)

1. Ramsay RR, Gandour RD, van der Leij FR. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 2001; 1546: 21-43.
2. Steiber A, Kerner J, Hoppel CL. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 2004; 25: 455-473.
3. Chace DH, Kalas TA, Naylor EW. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu Rev Genomics Hum Genet 2002; 3: 17-45.
4. Carpenter KH, Wiley V. Application of tandem mass spectrometry to biochemical genetics and newborn screening. Clin Chim Acta 2002; 322: 1-10.
5. Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 2001; 47: 1945-1955.
6. Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 2003; 111: 1399-1406.
7. Rashed MS, Bucknall MP, Little D, Awad A, Jacob M, Alamoudi M, et al. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated fagging of abnormal profles. Clin Chem 1997; 43: 1129-1141.
8. Cavedon CT, Bourdoux P, Mertens K, Van Thi HV, Herremans N, de Laet C, et al. Age-related variations in acylcarnitine and free carnitine concentrations measured by tandem mass spectrometry. Clin Chem 2005; 51: 745-752.
9. Meyburg J, Schulze A, Kohlmueller D, Linderkamp O, Mayate-pek E. Postnatal changes in neonatal acylcarnitine profile. Pediatr Res 2001; 49: 125-129.
10. Vijay S, Patterson A, Olpin S, Henderson MJ, Clark S, Day C, et al. Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants. J Inherit Metab Dis 2006; 29: 627-630.
11. Walter JH, Patterson A, Till J, Besley GT, Fleming G, Henderson MJ. Bloodspot acylcarnitine and amino acid analysis in cord blood samples: efficacy and reference data from a large cohort study. J Inherit Metab Dis 2009; 32: 95-101.
12. de Rooy L, Hawdon J. Nutritional factors that affect the postnatal metabolic adaptation of full-term small- and large-for-gestation-al-age infants. Pediatrics 2002; 109: E42.
13. Girard J. Metabolic adaptations to change of nutrition at birth. Biol Neonate 1990; 58 (Suppl 1): 3-15.
14. Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003; 3: 6.
15. Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001; 47: 1166-1182.
16. Wilcken B, Wiley V, Sim KG, Carpenter K. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr 2001; 138: 581-584.
17. Fingerhut R, Roschinger W, Muntau AC, Dame T, Kreischer J, Arnecke R, et al. Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin Chem 2001; 47: 1763-1768.
18. Talián GC, Komlósi K, Decsi T, Koletzko B, Melegh B. Determination of carnitine ester patterns during the second half of pregnancy, at delivery, and in neonatal cord blood by tandem mass spectrometry: complex and dynamic involvement of carnitine in the intermediary metabolism. Pediatr Res 2007; 62: 88-92.
19. Osorio JH, Pourfarzam M. Early diagnosis of neurometabolic diseases by tandem mass spectrometry. Acylcarnitine profle from cord blood. Rev Neurol 2004; 38: 11-16.
20. Osorio JH, Pourfarzam M. Carnitina libre y total en sangre de cordón umbilical. Rev Colomb Obstet Ginecol 2002; 53: 335-340.
21. Chace DH, Pons R, Chiriboga CA, McMahon DJ, Tein I, Naylor EW, et al. Neonatal blood carnitine concentrations: normative data by electrospray tandem mass spectometry. Pediatr Res 2003; 53: 823-829.
22. Honzík T, Chrastina R, Hansíková H, Böhm M, Martincová O, Plavka R, et al. Carnitine concentrations in term and preterm newborns at birth and during the frst days of life. Prague Med Rep 2005; 106: 297-306.
23. Crill CM, Helms RA. The use of carnitine in pediatric nutrition. Nutr Clin Pract 2007; 22: 204-213.
24. Millington DS, Norwood DL, Kodo N, Roe CR, Inoue F. Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue. Anal Biochem 1989; 180: 331-339.
25. Schmidt-Sommerfeld E, Zhang L, Bobrowski PJ, Penn D. Quantitation of short- and medium-chain acylcarnitines in plasma by radioisotopic exchange/high-performance liquid chromatography. Anal Biochem 1995; 231: 27-33.
26. Lowes S, Rose ME, Mills GA, Pollitt RJ. Identification of urinary acylcarnitines using gas chromatography-mass spectrometry: preliminary clinical applications. J Chromatogr 1992; 577: 205-214.
27. Rashed MS, Ozand PT, Harrison ME, Evans S. Electrospray tandem mass spectrometry in the diagnosis of organic acidemias. Rapid Commun Mass Spectrom 1994; 8: 129-133.
28. Rashed MS, Ozand PT, Bucknall MP, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995; 38: 324-331.
29. De Jesus V, Chace DH, Lim TH, Mei JV, Hannon WH. Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. Clin Chim Acta 2010; 411: 684-689.
30. Giovannini M, Agostoni C, Salari PC. Is carnitine essential in children? J Int Med Res 1991; 19: 88-102.
31. Warshaw JB, Curry E. Comparison of serum carnitine and ke-tone body concentrations in breast- and in formula-fed newborn infants. J Pediatr 1980; 97: 122-125.
32. Berghaus TM, Demmelmair H, Koletzko B. Fatty acid composition of lipid classes in maternal and cord plasma at birth. Eur J Pediatr 1998; 157: 763-768.
33. Akre J. Infant feeding. The physiological basis. Bull World Health Organ 1989; 67 (Suppl): 1-108.
34. Smit EN. Essential fatty acid deficiency in malnourished children: erythrocyte and breastmilk fatty acid compositions in different populations. [Doctoral thesis]. Groningen: University of Groningen, The Netherlands; 2002.
35. Patterson AL, Pourfarzam M, Henderson MJ. The utility of cord blood analysis in the diagnosis of organic acidaemias. J Inherit Metab Dis 2000; 23 (Suppl 1): 84 (Abstract).
36. Nassogne MC, Jakobs C, Brivet M, Sharrard M, Garcia A, Rabier D, et al. Evolution of plasma acylcarnitines pattern in a newborn with prenatal diagnosis of CPT II defciency: evidence of improvement upon carnitine supplementation. J Inherit Metab Dis 2000; 23 (Suppl 1): 116 (Abstract).
37. Isackson PJ, Bennett MJ, Lichter-Konecki U, Willis M, Nyhan WL, Sutton VR, et al. CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency. Mol Genet Metab 2008; 94: 422-427.
38. Yokoi K, Ito T, Maeda Y, Nakajima Y, Kurono Y, Sugiyama N, et al. A case of holocarboxylase synthetase deficiency with insufficient response to prenatal biotin therapy. Brain Dev 2009; 31: 775-778.
39. Santos L, Patterson A, Moreea SM, Lippiatt CM, Walter J, Henderson M. Acute liver failure in pregnancy associated with maternal MCAD deficiency. J Inherit Metab Dis 2007; 30: 103.
40. Botler J, Camacho LA, da Cruz MM, George P. Neonatal screening - the challenge of an universal and effective coverage. Cien Saude Colet 2010; 15: 493-508.